---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-281171"
form_type: "8-K"
ticker: "MNOV"
cik: "0001226616"
company_name: "MEDICINOVA INC"
filed_at: "2026-06-24T20:38:44+00:00"
generated_at: "2026-06-24T20:40:13.354650+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# MediciNova shareholders reject proposal to increase authorized shares to 247M at 2026 annual meeting

## Summary
- Class I directors Hikedi Nagao and Nicole Lemerond elected with ~20.9M and ~21.5M votes for, respectively.
- BDO USA ratified as auditor for FY 2026 with 26.7M votes for, 1.9M against.
- Proposal to increase authorized common shares from 100M to 247M failed with 22.2M for, 6.4M against; needed majority of outstanding shares.
- Adjournment proposal approved with 22.7M for, 5.8M against.

## SEC filing metadata
- accession: 0001193125-26-281171
- form_type: 8-K
- ticker: MNOV
- cik: 0001226616
- company_name: MEDICINOVA INC
- filed_at: 2026-06-24T20:38:44+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1226616/000119312526281171/0001193125-26-281171-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1226616/000119312526281171/mnov-20260623.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-281171
- JSON: https://secwatch.observer/filing/0001193125-26-281171.json
- Plain text: https://secwatch.observer/filing/0001193125-26-281171.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.